Highlights and Quick Summary
- Annual 3Y Reveue Growth (CAGR) for 2021 was 96.7% (a -986.34% decrease from previous year)
- Annual 3Y Reveue Growth (CAGR) for 2020 was -10.91% (a -147.79% decrease from previous year)
- Annual 3Y Reveue Growth (CAGR) for 2019 was 22.83% (a -192.65% decrease from previous year)
Visit stockrow.com/BCRX
for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow
statement with 10 years of data, and state-of-the-art screener.
Historical 3Y Reveue Growth (CAGR) of BioCryst Pharmaceuticals, Inc.
Most recent 3Y Reveue Growth (CAGR)of BCRX including historical data for past 10 years.Interactive Chart of 3Y Reveue Growth (CAGR) of BioCryst Pharmaceuticals, Inc.
BioCryst Pharmaceuticals, Inc. 3Y Reveue Growth (CAGR) for the past 10 Years (both Annual and Quarterly)
| Year | Q1 | Q2 | Q3 | Q4 | Fiscal Year |
|---|---|---|---|---|---|
| 2021 | – | – | – | – | 96.7% |
| 2020 | – | – | – | – | -10.91% |
| 2019 | – | – | – | – | 22.83% |
| 2018 | – | – | – | – | -24.64% |
| 2017 | – | – | – | – | 22.78% |
| 2016 | – | – | – | – | 14.99% |
| 2015 | – | – | – | – | 22.44% |
| 2014 | – | – | – | – | -11.52% |
| 2013 | – | – | – | – | -34.75% |
| 2012 | – | – | – | – | -18.32% |
Business Profile of BioCryst Pharmaceuticals, Inc.
Sector: Healthcare
Industry: Biotechnology